Profile
HITI ONC WBA DFTX HROWL HROWM
Company Name High Tide Inc. BeOne Medicines Ltd. Walgreens Boots Alliance, Inc. Definium Therapeutics, Inc. Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 11.875% Senior Notes due 2027
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals
Market Cap $206.42M $36.98B $10.37B $1.58B $1.37B $1.34B
Employees 1.75K 11.00K 193.00K 0.07K 0.22K 0.22K
CEO Harkirat Grover John V. Oyler Timothy C. Wentworth Robert Barrow Mark L. Baum Mark L. Baum
Ratings
Trading
HITI ONC WBA DFTX HROWL HROWM
Last Close $2.63 $376.63 $11.98 - $25.61 $26.03
High 52 $3.98 $377.81 $12.93 - $25.72 $26.95
Low 52 $1.71 $175.1 $8.24 - $25.01 $25.85
Price vs. 52 Week High -33.92 % -0.31 % -7.35 % - -0.43 % -3.41 %
Price vs. 52 Week Low 53.8 % 115.09 % 45.39 % - 2.4 % 0.7 %
Total Return
HITI ONC WBA DFTX HROWL HROWM
1 Month Return -21.02 % 19.03 % 0 % - 0 % 0 %
3 Month Return -11.74 % 17.95 % -0.17 % - 0.55 % -1.33 %
6 Month Return 11.44 % 64.91 % 6.11 % - 1.23 % -0.78 %
9 Month Return 1.15 % 58 % 8.32 % - 1.13 % -2.87 %
YTD Return -14.89 % 104.69 % 28.4 % - 1.32 % -0.69 %
1 Year Return -1.5 % 0 % 44.51 % - 1.31 % -1.03 %
3 Year Return 0 % 0 % 0 % - 0 % 0 %
5 Year Return 0 % 0 % 0 % - 0 % 0 %
Dividends
HITI ONC WBA DFTX HROWL HROWM
Dividend Yield Percentage (TTM) - - - - - -
Dividend Paid and Capex Coverage Ration (TTM) 1.99 % 2.45 % 0.96 % - 0.46 % 0.46 %
Dividend Per Share (TTM) - - - - - -
Payout Ratio (TTM) -2.76 % - -10.29 % - - -
Growth
HITI ONC WBA DFTX HROWL HROWM
Asset Growth 41.76 % 1.99 % -16.14 % 24.77 % 24.77 %
Gross Profit Growth -62.71 % 54.71 % -2.02 % 66.06 % 66.06 %
Revenue Growth 13.71 % 54.96 % 6.17 % 53.32 % 53.32 %
Revenue 3 Year 27.13 % 185.46 % 11.65 % 106.71 % 106.71 %
Revenue 5 Year 32.51 % 407.52 % 31.29 % 177.12 % 177.12 %
Revenue 10 Year 3826.39 % 14520 % 113.45 % 2980.55 % 2980.55 %
EBIT Growth -553.5 % 52.95 % -183.88 % 1018.99 % 1018.99 %
Net Income Growth -1069.94 % 26.87 % -180.39 % 28.39 % 28.39 %
Net Income 3 Yeari Growth Per Share 45.29 % 61.02 % -440.4 % 27.14 % 27.14 %
Net Income 5 Yeari Growth Per Share -48.35 % 61.23 % -331.55 % -7491.01 % -7491.01 %
Net Income 10 Yeari Growth Per Share -2402.1 % -1664.38 % -593.61 % 55.74 % 55.74 %
Operating Income Growth 208.51 % 52.95 % -104.53 % 1946.87 % 1946.87 %
Operating Cash Flow Growth (CFG) -32.87 % 87.85 % -54.92 % -678.18 % -678.18 %
Operating 3 Year CFG 305.53 % 90.46 % -81.64 % -427.89 % -427.89 %
Operating 5 Year CFG -49.91 % 89.31 % -80.57 % -1760.03 % -1760.03 %
Operating 10 Year CFG 4443.21 % -709.03 % -71.12 % 19.39 % 19.39 %
EPS Growth -1037.61 % 27.57 % -180.39 % 34.67 % 34.67 %
EPS Diluted Growth -1037.61 % 27.57 % -180.39 % 34.67 % 34.67 %
Book Value Per Share -31.62 % -6.6 % -57.24 % -9.43 % -9.43 %
Share Holder 3 Year Equity Growth Per Share -57.2 % -52.12 % -56.07 % 363.19 % 363.19 %
Share Holder 5 Year Equity Growth Per Share 60 % 97.53 % -53.83 % 78.54 % 78.54 %
Share Holder 10 Year Equity Growth Per Share 589.34 % 6367.84 % -43.9 % 118.93 % 118.93 %
Dividend Per Share Growth - - -24.04 % - -
Dividend 3 Year Growth Per Share -45.35 % - -21.92 % -100 % -100 %
Dividend 5 Year Growth Per Share - - -18.12 % - -
Dividend 10 Year Growth Per Share 398.2 % - 16.05 % - -
Debt Growth 100.78 % 16.09 % 0.7 % 20.12 % 20.12 %
Free Cash Flow Growth -47.95 % 61.81 % -357.45 % 59.06 % 59.06 %
Updated On 31 Oct 2025 31 Dec 2024 31 Aug 2024 31 Dec 2024 31 Dec 2024
Profitability
HITI ONC WBA DFTX HROWL HROWM
Gross Profit Margin TTM 25.85 % 86.11 % 17.13 % - 74.56 % 74.56 %
Return on Assets TTM -14.54 % 1.06 % -9.07 % -70.95 % -1.37 % -1.37 %
Return on Equity TTM -39.66 % 2.19 % -70.17 % -86.18 % -8.96 % -8.96 %
Return on Capital Employed TTM 6.2 % 3.06 % -7.17 % -88.16 % 9.35 % 9.35 %
Net Income Per EBT TTM 98.67 % 39.97 % 107.6 % 100 % 90.66 % 90.66 %
EBT Per Ebit TTM -333.15 % 125.31 % 187.84 % 111.18 % -19.78 % -19.78 %
EBIT Per Revenue TTM 2.6 % 3.2 % -2.02 % - 11.13 % 11.13 %
Cash Flow To Debt Ratio TTM 15.93 % 77 % 5.43 % -282.12 % 7.02 % 7.02 %
Receivables Turnover TTM 105.79 5.83 23.42 - 3.21 3.21
Payables Turnover TTM 15.86 1.82 9.41 - 3.35 3.35
Inventory Turnover TTM 6.53 1.31 17.5 - 4.96 4.96
Fixed Asset Turnover TTM 769.12 % 284.64 % 556.84 % - 2202.82 % 2202.82 %
Asset Turnover TTM 170.17 % 65.95 % 222.72 % - 68.87 % 68.87 %
Operating Cash Flow Per Share TTM 0.27 7.13 1.82 -1.33 0.48 0.48
Free Cash Flow Per Share TTM 0.15 4.22 0.67 -1.33 -0.55 -0.55
Cash Per Share TTM 54.81 % 3662.7 % 95.96 % 243.43 % 200 % 200 %
Operating Cash Flow Sales Ratio TTM 4.02 % 15.6 % 1.02 % - 7.07 % 7.07 %
Free Cash Flow Operating Cash Flow Ratio TTM 55.75 % 59.15 % 36.78 % 100 % -115.84 % -115.84 %
Cash Flow Coverage Ratios TTM 15.93 % 77 % 5.43 % -282.12 % 7.02 % 7.02 %
Price To Free Cash Flows Ratio TTM 21.26 91.17 17.88 -13.85 -86.27 -85.24
Price To Operating Cash Flows Ratio TTM 11.8 5.68 6.57 -12.23 100.23 99.03
Price Cash Flow Ratio TTM 11.8 5.68 6.57 -12.23 100.23 99.03
Income Statement (TTM)
HITI ONC WBA DFTX HROWL HROWM
Revenue $0.59B $3.81B $147.66B $0B $0.2B $0.2B
Gross Profit $0.15B $3.22B $26.52B $-0B $0.15B $0.15B
Gross Profit Ratio 25.85% 84.41% 17.96% 0% 75.33% 75.33%
EBITDA $-0.01B $-0.4B $-11.28B $-0.11B $0.02B $0.02B
Net Income $-0.05B $-0.64B $-8.64B $-0.11B $-0.02B $-0.02B
EPS Diluted -0.62 -6.12 -10.01 -0.15 -0.49 -0.49
Balance Sheet (MRQ)
HITI ONC WBA DFTX HROWL HROWM
Long Term Debt $0.12B $0.21B $29.88B $0.02B $0.23B $0.23B
Total Liabilities $0.25B $2.59B $68.86B $0.06B $0.32B $0.32B
Total Equity $0.1B $3.33B $12.18B $0.24B $0.07B $0.07B
Total Investments $0B $0.13B $4.06B $0B $0B $0B
Total Debt $0.15B $1.08B $33.77B $0.02B $0.23B $0.23B
Total Assets $0.35B $5.92B $81.04B $0.3B $0.39B $0.39B
Cash Flow Statement (TTM)
HITI ONC WBA DFTX HROWL HROWM
Net Income $-0.05B $-0.64B $-15.45B $-0.11B $-0.02B $-0.02B
Inventory $-0.01B $-0.09B $-0.03B $0B $0B $0B
Dividends Paid $-0B $0B $-1.26B $0B $0B $0B
Operating Cash Flow $0.02B $-0.14B $1.02B $-0.08B $-0.02B $-0.02B
Capital Expenditure $-0.01B $-0.53B $-1.38B $0B $-0.04B $-0.04B
Related Stocks
Ticker Name Price
AIXC Qualigen Therapeutics, Inc. 1.3
ATAI Atai Life Sciences N.V. 3.57
ATNFW CannBioRx Life Sciences Corp. 0.43
BGMS Bio Green Med Solution, Inc. 0.9806
BGMSP Bio Green Med Solution, Inc. 3.79
BIMI BIMI International Medical Inc. 0.0001
CGEM Cullinan Oncology, Inc. 11.59
CJJD China Jo-Jo Drugstores, Inc. 1.52
DFTX Mind Medicine (MindMed) Inc. 15.75
HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares 0.799
HROWL Harrow Health, Inc. 8.625% Senior Notes due 2026 25.61
HROWM Harrow Health, Inc. 11.875% Senior Notes due 2027 26.03
KYNB FibroGen, Inc. 7.45
LFLY Leafly Holdings, Inc. 37
LFLYW Leafly Holdings, Inc. 0.004
LFMD LifeMD, Inc. 2.78
LFMDP LifeMD, Inc. 22.5
MDVL MedAvail Holdings, Inc. 1.8
MEDS TRxADE HEALTH, Inc. 7.59
MSLE Satellos Bioscience Inc. Common Stock 11.5
ETFs With Exposure to HITI
Ticker ETF Name Weight Percentage Price
MJ ETFMG Alternative Harvest ETF 2.76 25.25
YOLO AdvisorShares Pure Cannabis ETF 8.96 2.88
Unlock